The in vitro construction of a tissue engineered bioprosthetic heart valve

European Journal of Cardio-thoracic Surgery

Volumn 11, Issue 3, 1997, Pages 493-497

  Zund, G ^a   Breuer, C K ^a   Shinoka, T ^a   Ma, P X ^b   Langer, R ^b   Mayer, J E ^a   Vacanti, J P ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

Bioprosthetic heart valve; Endothelial cells; Myofibroblast; Synthetic biodegradable matrix; Tissue engineering

Indexed keywords

ANIMAL CELL; ARTICLE; BIOPROSTHESIS; CATTLE; ENDOTHELIUM CELL; ENGINEERING; HEART VALVE PROSTHESIS; HISTOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; SKIN FIBROBLAST;

ANIMALS; BIOPROSTHESIS; CATTLE; CELL DIFFERENTIATION; ENDOTHELIUM, VASCULAR; FACTOR VIII; FIBROBLASTS; HEART VALVE PROSTHESIS; HUMANS; IMMUNOENZYME TECHNIQUES; MUSCLE, SMOOTH, VASCULAR; SHEEP;

EID: 0030975431     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(96)01005-6     Document Type: Article

References (18)

1. Bruce EJ, Williams SK. Microvessel derived endothelial cell isolation, adherence, and monolayer formation for vascular grafts. J Vas Surg 1991;13(5):733-734.
2. Cannegieter SC, Rosendaal FR. Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994;89(2):635-641.
3. Cao Y, Vacanti JP, Ma X. et al. Generation of neo-tendon using synthetic polymers seeded with tenocytes. Transplant Proc 1994;26(6):3390-3391.
4. Greentree D, Marelli D, Ma F, Chiu RC-J. Satellite cell transplantation for myocardial repair: labeling techniques. Transplant Proc 1994;26(6):3357.
5. Hammermeister KE, Gulshan KS, William GH, Oprian C, Kim T, Rahimtoola S. A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis. N Eng J Med 1993;328(18):1289-1296.
6. Harken DE, Soroff HS, Taylor WJ, Lefemine AA, Gupta SK, Lunzer S. Partial and complete prostheses in aortic insufficiency. J Thorac Cardiovas Surg 1960;40(6):744-762.
7. American Heart Association. Heart and stroke facts: statistical supplement. 1994.
8. Kirklin JK, Smith D, Novick W, et al. Long-term function of cryopreserved aortic homografts. J Thorac Cardiovas Surg 1993;106:154-166.
9. Langer R, Vacanti JP. Tissue Engineering. Science 1993;260:920-926.
10. Marelli D, Desrosiers C, el-Alfy M, Kao RL, Chiu RC. Cell transplantation for myocardial repair: an experimental approach. Cell Transplant 1992;1(6):383-390.
11. Mooney DJ, Organ G, Vacanti JP, Langer R. Design and fabrication of biodegradable polymer devices to engineer tubular tissues. Cell Transplant 1994;3(2):203-210.
12. Muller-Glauser W, Lehmann KH, Bittmann P et al. A compliant small-diameter vascular prosthesis lined with functional venous endothelial cells. ASAIO Trans 1988;34(3):528-531.
13. Sakata J, Vacanti CA, Schloo B, Healy GB, Langer R, Vacanti JP. Trachel composites tissue engineered from chondrocytes, trachel epithelial cells, and synthetic degradable scaffolding. Transplant Proc 1994;26(6):3309-3310.
14. Starr A, Edwards ML. Mitral replacement: clinical experience with a ball-valve prosthesis. Ann Surg 1961;154(4):726-740.
15. Vacanti CA, Vacanti JP. Bone and cartilage reconstruction with tissue engineering approaches. Otolaryngol Clin North Am 1994;27(1):263-276.
16. Vacanti JP, Morse MA, Saltzman WM, Domb AJ, Perez-Atayade A, Langer R. Selective cell transplantation using bioabsorbable artificial polymers as matrices. J Pediatr Surg 1988;23(1):3-9.
17. Vacanti JP. Beyond transplantation: Third Annual Samuael Jason Mixter Lecture. Arch Surg 1988;123:545-549.
18. Zibaitis A, Greentree D, Ma F, Marelli D, Duong M, Chiu RC-J. Myocardial regeneration with satellite cell implantation. Transplant Proc 1994;26(6):3294.